Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and beauty retail company. It operates through two segments, the United States and International. The United States segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores. It also provides central specialty pharmacy services and mail services. As of August 31, 2021, this segment operated 8,965 retail stores under the Walgreens and Duane Reade brands in the United States; and five specialty pharmacies. The International segment sells prescription drugs; and health and wellness, beauty, personal care, and other consumer products through its pharmacy-led health and beauty retail stores and optical practices, as well as through boots.com and an integrated mobile application. It also engages in pharmaceutical wholesaling and distribution business in Germany. As of August 31, 2021, this segment operated 4,031 retail stores under the Boots, Benavides, and Ahumada in the United Kingdom, Thailand, Norway, the Republic of Ireland, the Netherlands, Mexico, and Chile; and 548 optical practices, including 160 on a franchise basis. Walgreens Boots Alliance, Inc. was founded in 1901 and is based in Deerfield, Illinois.
Over the last 12 months, insiders at Walgreens Boots Alliance, Inc. have bought $512,643 and sold $350,567 worth of Walgreens Boots Alliance, Inc. stock.
On average, over the past 5 years, insiders at Walgreens Boots Alliance, Inc. have bought $499,568 and sold $398,000 worth of stock each year.
Highest buying activity among insiders over the last 12 months: WENTWORTH TIMOTHY C (Chief Executive Officer) — $484,440. JARRETT VALERIE B (director) — $299,978. Mahajan Manmohan (EVP and Global CFO) — $116,280.
The last purchase of 3,000 shares for transaction amount of $54,150 was made by Bhandari Inderpal S (director) on 2024‑04‑11.
2024-04-11 | director | 3,000 0.0003% | $18.05 | $54,150 | -39.80% | |||
2024-04-02 | EVP and Global CFO | 6,000 0.0007% | $19.38 | $116,280 | -39.64% | |||
2024-01-29 | director | 4,456 0.0005% | $22.44 | $99,993 | -29.70% | |||
2024-01-16 | Sale | director | 15,209 0.0018% | $23.05 | $350,567 | -30.30% | ||
2024-01-05 | Chief Executive Officer | 10,000 0.0011% | $24.22 | $242,220 | -34.96% | |||
2023-11-10 | Sale | SVP, Chief Pharmacy Officer | 1,000 0.0001% | $20.45 | $20,450 | -13.14% | ||
2023-06-30 | EVP, Pres. U.S. Healthcare | 5,172 0.0006% | $28.42 | $146,984 | -23.94% | |||
2023-03-29 | CEO | 10,000 0.0012% | $33.95 | $339,510 | -28.17% | |||
2022-11-18 | Sale | EVP, Chief Medical Officer | 10,303 0.0012% | $40.19 | $414,108 | -18.41% | ||
2022-11-17 | Sale | director | 16,570 0.0019% | $39.89 | $660,928 | -19.14% | ||
2021-11-19 | Sale | director | 2,725 0.0003% | $47.16 | $128,497 | -6.94% | ||
2020-11-11 | Sale | EVP, Global CAO and GC | 10,000 0.0012% | $41.55 | $415,450 | +21.52% | ||
2019-11-05 | Sale | EVP, Global CAO and GC | 468,710 0.0543% | $63.16 | $29.6M | -28.46% | ||
2019-08-15 | Sale | EVP, Global CAO and GC | 246,992 0.0272% | $50.06 | $12.36M | +3.23% | ||
2019-08-14 | Sale | EVP, Global CAO and GC | 183,654 0.0202% | $51.03 | $9.37M | +0.91% | ||
2019-05-09 | Sale | EVP, Global CAO and GC | 40,000 0.0044% | $53.05 | $2.12M | +0.56% | ||
2019-04-03 | Co-Chief Operating Officer | 36,000 0.0039% | $54.56 | $1.96M | -0.93% | |||
2018-11-20 | Sale | director | 14,100 0.0015% | $78.81 | $1.11M | -29.63% | ||
2018-11-01 | Sale | director | 5,472 0.0006% | $79.48 | $434,915 | -29.34% | ||
2018-11-01 | Sale | SVP, Global Controller and CAO | 15,705 0.0017% | $79.79 | $1.25M | -29.34% |
WENTWORTH TIMOTHY C | Chief Executive Officer | 585122 0.0677% | $9.02 | 1 | 0 | |
Mahajan Manmohan | EVP and Global CFO | 166969 0.0193% | $9.02 | 1 | 0 | |
JARRETT VALERIE B | director | 4456 0.0005% | $9.02 | 1 | 0 | |
Bhandari Inderpal S | director | 3000 0.0003% | $9.02 | 1 | 0 | |
SCHLICHTING NANCY M | director | 0 0% | $9.02 | 0 | 4 | |
Pessina Stefano | Executive Vice Chairman, CEO | 144788821 16.746% | $9.02 | 3 | 1 | +4.43% |
Rosenstein Barry | director | 4579100 0.5296% | $9.02 | 0 | 6 | |
Barra Ornella | Co-Chief Operating Officer | 1718000 0.1987% | $9.02 | 3 | 1 | +1.29% |
Gourlay Alexander W. | EVP and President of Walgreens | 734389 0.0849% | $9.02 | 0 | 1 | |
Fairweather George Rollo | EVP and Global CFO | 513563 0.0594% | $9.02 | 0 | 1 | |
BREWER ROSALIND G | CEO | 369945 0.0428% | $9.02 | 1 | 0 | <0.0001% |
Gates Richard P. | SVP, Chief Pharmacy Officer | 73929 0.0086% | $9.02 | 0 | 1 | |
DRISCOLL JOHN PATRICK | EVP, Pres. U.S. Healthcare | 59050 0.0068% | $9.02 | 1 | 0 | <0.0001% |
Wilson-Thompson Kathleen | EVP and Global Chief HRO | 55676 0.0064% | $9.02 | 0 | 8 | |
Lederer John Anthony | director | 50000 0.0058% | $9.02 | 4 | 0 | <0.0001% |
SABATINO THOMAS J JR | EVP, Global CLO and CAO | 44536 0.0052% | $9.02 | 0 | 1 | |
Pagni Marco Patrick Anthony | EVP, Global CAO and GC | 34700 0.004% | $9.02 | 0 | 5 | |
Ban Kevin M. | EVP, Chief Medical Officer | 27916 0.0032% | $9.02 | 0 | 1 | |
FOOTE WILLIAM C | director | 8207 0.0009% | $9.02 | 0 | 11 | |
SCHAEFFER LEONARD D | director | 1512 0.0002% | $9.02 | 1 | 0 | <0.0001% |
GRAHAM GINGER L | director | 2150 0.0002% | $9.02 | 1 | 0 | +4.1% |
Babiak Janice M. | director | 1200 0.0001% | $9.02 | 2 | 0 | +2.2% |
Murphy Ken | EVP, Chief Commercial Officer | 653 0.0001% | $9.02 | 0 | 1 | |
Scardino Kimberly R | SVP, Global Controller and CAO | 0 0% | $9.02 | 0 | 1 |
The Vanguard Group | $1.78B | 9.53 | 82.26M | -1.06% | -$19.1M | 0.03 | |
BlackRock | $1.48B | 7.89 | 68.13M | +3.4% | +$48.58M | 0.03 | |
State Street | $785.04M | 4.19 | 36.19M | -33.2% | -$390.11M | 0.03 | |
Capital World Investors | $630.33M | 3.37 | 29.06M | +57.52% | +$230.18M | 0.11 | |
Geode Capital Management | $409.49M | 2.19 | 18.88M | +13.99% | +$50.25M | 0.04 | |
Invesco | $375.39M | 2.01 | 17.31M | -9.16% | -$37.85M | 0.08 | |
Morgan Stanley | $273.32M | 1.46 | 12.6M | -25.69% | -$94.47M | 0.02 | |
Camber Capital Management Lp | $169.18M | 0.9 | 7.8M | +11.43% | +$17.35M | 5.96 | |
Northern Trust | $159.13M | 0.85 | 7.34M | -0.48% | -$770,190.21 | 0.03 | |
Legal & General | $157.13M | 0.84 | 7.24M | -1.53% | -$2.43M | 0.04 | |
Charles Schwab | $152.59M | 0.82 | 7.03M | +7.9% | +$11.17M | 0.03 | |
JPMorgan Chase | $135.11M | 0.72 | 6.23M | +74.33% | +$57.61M | 0.01 | |
Goldman Sachs | $126.01M | 0.67 | 5.81M | +25.53% | +$25.63M | 0.02 | |
BNY Mellon | $119.28M | 0.64 | 5.5M | -7.6% | -$9.81M | 0.02 | |
Ubs Asset Management Americas Inc | $116.27M | 0.62 | 5.36M | -3.73% | -$4.5M | 0.04 | |
Sessa Capital Master L P | $103.43M | 0.55 | 4.77M | +26.34% | +$21.56M | 4.03 | |
Allianz Asset Management Gmbh | $99.1M | 0.53 | 4.57M | +16.61% | +$14.12M | 0.17 | |
LSV Asset Management | $88.09M | 0.47 | 4.06M | -9.99% | -$9.77M | 0.18 | |
Barclays | $81.16M | 0.43 | 3.74M | +6.34% | +$4.84M | 0.04 | |
Dimensional Fund Advisors | $76.04M | 0.41 | 3.51M | +4.8% | +$3.48M | 0.02 | |
Amundi | $53.51M | 0.35 | 3.04M | +63.91% | +$20.86M | 0.02 | |
Susquehanna International Group | $65.71M | 0.35 | 3.03M | +403.34% | +$52.66M | 0.07 | |
TSW (Thompson, Siegel & Walmsley LLC) | $65.69M | 0.35 | 3.03M | New | +$65.68M | 1.01 | |
UBS | $64.31M | 0.34 | 2.97M | -17.82% | -$13.94M | 0.02 | |
Royal Bank of Canada | $61.2M | 0.33 | 2.82M | +5.03% | +$2.93M | 0.02 | |
Schroder Investment Management Group | $60.28M | 0.32 | 2.78M | +23.54% | +$11.49M | 0.07 | |
Man Group Plc | $56.11M | 0.3 | 2.59M | +58.3% | +$20.66M | 0.14 | |
Fidelity Investments | $55.86M | 0.3 | 2.58M | +114.08% | +$29.76M | <0.01 | |
Sumitomo Mitsui Trust Holdings | $55.57M | 0.3 | 2.56M | -16.74% | -$11.17M | 0.04 | |
Millennium Management LLC | $52.47M | 0.28 | 2.42M | +71.11% | +$21.81M | 0.03 | |
Deutsche Bank | $51.4M | 0.28 | 2.37M | +8.29% | +$3.94M | 0.02 | |
Swiss National Bank | $47.61M | 0.25 | 2.2M | -4.4% | -$2.19M | 0.03 | |
First Trust | $47.25M | 0.25 | 2.18M | -33.98% | -$24.32M | 0.05 | |
Balyasny Asset Management Llc | $46.59M | 0.25 | 2.15M | +18.16% | +$7.16M | 0.13 | |
Ameriprise Financial | $41.78M | 0.22 | 1.93M | +91.29% | +$19.94M | 0.01 | |
Nuveen | $40.01M | 0.21 | 1.84M | -5.45% | -$2.31M | 0.01 | |
Ariel Investments | $39.91M | 0.21 | 1.84M | +25.29% | +$8.06M | 0.39 | |
Renaissance Technologies | $39.68M | 0.21 | 1.83M | New | +$39.68M | 0.06 | |
Citigroup | $39.49M | 0.21 | 1.82M | +46.57% | +$12.55M | 0.03 | |
Grantham Mayo Van Otterloo & Co LLC | $39.13M | 0.21 | 1.8M | -3.4% | -$1.38M | 0.12 | |
Bank of America | $38.73M | 0.21 | 1.79M | +40.71% | +$11.2M | <0.01 | |
Wells Fargo | $35.99M | 0.19 | 1.66M | -21.44% | -$9.82M | 0.01 | |
Bank of Montreal | $36.01M | 0.19 | 1.66M | -7.54% | -$2.93M | 0.01 | |
National Pension Service | $34.49M | 0.18 | 1.59M | +2.47% | +$831,030.65 | 0.04 | |
Hrt Financial Llc | $32.74M | 0.18 | 1.51M | +3,419% | +$31.81M | 0.21 | |
De Depot Et Placement Du Quebec Caisse | $32.54M | 0.17 | 1.5M | +349.29% | +$25.29M | 0.08 | |
Citadel Advisors LLC | $32.41M | 0.17 | 1.49M | +303.41% | +$24.38M | 0.02 | |
HSBC | $31.29M | 0.17 | 1.44M | -16.68% | -$6.27M | 0.02 | |
RhumbLine Advisers | $30.16M | 0.16 | 1.39M | +0.36% | +$107,083.16 | 0.03 | |
Integral Health Asset Management Llc | $28.2M | 0.15 | 1.3M | +18.18% | +$4.34M | 2.83 |